SEC16 Antibody

What is SEC16 and what is its fundamental role in cellular transport?

SEC16 is a protein that mediates the biogenesis of transitional ER (tER) sites, which are specialized cup-shaped ER subdomains characterized by the focused budding of COPII vesicles. It functions upstream of the COPII machinery in the secretory pathway . In mammalian cells, SEC16 defines endoplasmic reticulum exit sites (ERES) and localizes to these sites independent of other COPII components like Sec23/24 and Sec13/31 . The protein appears to function as an organized scaffold that defines ERES, playing a critical role in ER-to-Golgi transport. SEC16A, the human homolog, has a calculated molecular weight of 234 kDa but is observed at 250-300 kDa in experimental settings .

What applications can SEC16A antibodies be used for in research?

SEC16A antibodies have been validated for multiple experimental applications:

The antibody has shown positive reactivity in Western blots of HEK-293 and HeLa cells, immunoprecipitation from HeLa cells, immunohistochemistry in mouse pancreas tissue, immunofluorescence in A431 cells, and flow cytometry in HEK-293 cells .

What species reactivity does the SEC16A antibody demonstrate?

Commercial SEC16A antibodies have been tested and show reactivity with human, mouse, and rat samples . This cross-species reactivity is valuable for comparative studies across different model systems. When designing experiments, it's important to verify species reactivity for your specific antibody, as epitope conservation may vary between different antibody clones.

What are the optimal storage conditions for SEC16A antibodies?

The SEC16A antibody should be stored in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . This formulation helps maintain antibody stability and functionality during long-term storage. For optimal preservation of activity, antibodies should be stored at -20°C and aliquoted to avoid repeated freeze-thaw cycles that could degrade the antibody.

How does SEC16 mechanistically contribute to ER exit site formation?

SEC16 plays a foundational role in ERES formation by functioning upstream of the COPII machinery. Research shows that dSec16 can associate with discrete ER domains even in the absence of assembled tER sites, COPII vesicles, and Sar1, indicating its primary role in ERES establishment . The mechanism involves a complex interplay with Sar1, where SEC16 and Sar1 have an interdependent relationship. While the localization of SEC16 to the ER membrane depends on Sar1-GTP, the stable accumulation of Sar1-GTP-Sec23/24-cargo complexes also requires SEC16 .

A proposed model suggests that Sar1-GDP can be activated to Sar1-GTP by Sec12 across the ER membrane, which allows sampling of membrane proteins for inclusion in budding vesicles and binding of Sec23/24 to both Sar1-GTP and transmembrane cargo . SEC16 appears to assemble on the ER membrane, with its persistence controlled by the GTPase activity of Sar1. This assembly is thought to coordinate the formation of the COPII pre-budding complex, providing spatial coordination for productive COPII budding events .

What specific domains of SEC16 are essential for its localization and function?

The localization of SEC16 to tER sites has been linked to specific protein domains. In Drosophila, the domain involved in dSec16 localization to tER sites was identified as a stretch of 65 amino acids forming an arginine-rich domain in the N-terminal nonconserved region of the protein . This suggests that the targeting mechanism may involve charge-based interactions rather than specific sequence recognition.

For experimental investigations of SEC16 domains, researchers should consider domain-specific antibodies or expression constructs with specific domain deletions or mutations. When using antibodies targeting specific domains, it's crucial to consider whether the epitope is accessible in the folded protein and whether post-translational modifications might affect antibody binding.

How does SEC16 expression level affect protein secretion pathways?

This evidence suggests that SEC16 expression must be tuned to an optimal level to facilitate efficient ER-to-Golgi transport. Too little SEC16 impairs transport, while too much can block transport or even be lethal to cells . A similar phenomenon occurs in mammalian cells, which require an appropriate amount of SEC16 to maintain ER-to-Golgi transport .

For researchers studying protein secretion pathways, this suggests using inducible or moderate-strength promoters when manipulating SEC16 expression, rather than very strong constitutive promoters.

What are the technical considerations for validating SEC16A antibody specificity?

Validating antibody specificity is crucial for reliable research outcomes. For SEC16A antibodies, several approaches are recommended:

• Knockdown/Knockout Controls: The antibody has been used in knockdown/knockout studies according to published applications . Compare SEC16A detection in wild-type cells versus SEC16A-depleted cells (using siRNA or CRISPR-Cas9). In SEC16-depleted cells, the signal should be significantly reduced or absent.

• Molecular Weight Verification: Confirm that the detected band appears at the expected molecular weight (250-300 kDa for SEC16A) . Note that this is higher than the calculated molecular weight (234 kDa), likely due to post-translational modifications.

• Multiple Detection Methods: Validate findings using different applications (e.g., WB, IF, IP) to ensure consistent results across techniques.

• Peptide Competition: Pre-incubate the antibody with the immunizing peptide before application to confirm that this blocks specific binding.

• Cross-Reference: Compare results from multiple SEC16A antibodies targeting different epitopes if available.

How can SEC16A antibodies be used to study ER stress responses?

SEC16 plays a role in ER stress responses, with moderate overexpression showing reduced ER stress in heterologous protein production systems . To study this connection:

• ER Membrane Quantification: Use SEC16A antibodies in combination with ER-specific dyes or markers to quantify changes in ER membrane volume under different stress conditions. Research has shown that when yeast cells produced α-amylase, the ER membrane expanded by approximately 25%, but when these cells also moderately overexpressed SEC16, the amount of ER membrane produced was smaller .

• Stress Marker Co-localization: Perform dual immunofluorescence with SEC16A antibodies and ER stress markers (e.g., Kar2p/BiP) to examine their relationship during stress responses. Detection of Kar2p in the extracellular medium can indicate an impaired secretory pathway, and less Kar2p has been detected in the medium of cells with moderate SEC16 overexpression .

• Trafficking Dynamics: Use pulse-chase experiments combined with SEC16A immunoprecipitation to track changes in protein interactions during ER stress.

• ERES Morphology Analysis: Quantify changes in the number and size of SEC16A-positive puncta (representing ERES) under different stress conditions using high-resolution microscopy.

• Phosphorylation Status: Investigate post-translational modifications of SEC16A during ER stress using phospho-specific antibodies or mass spectrometry following SEC16A immunoprecipitation.

What is the relationship between SEC16 and other COPII components in experimental systems?

SEC16 functions in close coordination with other COPII components, particularly Sar1. Research indicates that Sar1 concentration at tER sites is SEC16-dependent . In SEC16-depleted cells, Sar1 is no longer concentrated on tER sites but is dispersed throughout the ER . Conversely, artificially localizing SEC16 to endosomes allows recruitment of Sar1 and other COPII subunits, demonstrating that SEC16 is part of the machinery that regulates the positioning and building of tER sites .

For studying these interactions:

• Co-immunoprecipitation: Use SEC16A antibodies for IP followed by western blotting for other COPII components to detect interactions and how they change under different conditions.

• Proximity Ligation Assays: Combine SEC16A antibodies with antibodies against other COPII components to visualize and quantify protein-protein interactions in situ.

• FRET/FLIM Analysis: For higher resolution interaction studies, use fluorescently tagged proteins with SEC16A antibodies in FRET experiments.

• Sequential Depletion Experiments: Analyze the effects of depleting SEC16 followed by other COPII components to establish hierarchical relationships in ERES formation.